Pneumocystis jirovecii, formerly Pneumocystis carinii, has long been known to cause
disease in humans, particularly as an opportunistic pathogen of immunocompromised hosts …

Pneumocystis jiroveci, alternatively designated Pneumocystis carinii, remains an important
opportunistic pathogen among immunocompromised patient populations in not only the …

Pneumocystis jiroveci remains an important pathogen in immunocompromised individuals
despite a variety of effective antimicrobial strategies. In most solid organ transplant …

Pneumocystis jiroveci, previously P. carinii, is the quintessential opportunistic infection
among immunocompromised patients (1). Despite the availability of effective prophylaxis, P …

Pneumocystis jirovecii pneumonia (PJP) is an opportunistic infection diagnosed in
immunocompromized patients. After solid organ transplantation, early infection has …

These updated guidelines from the Infectious Diseases Community of Practice of the
American Society of Transplantation review the diagnosis, prevention, and management of …

Pneumocystis carinii remains an important pathogen in patients who undergo solid-organ
and hematopoietic transplantation. Infection results from reactivation of latent infection and …

Pneumocystis pneumonia (PCP) is well known and described in AIDS patients. Due to the
increasing use of cytotoxic and immunosuppressive therapies, the incidence of this infection …

Background Pneumocystis jirovecii pneumonia (PCP) is a life‐threatening infection for
immunocompromised individuals. Robust data and clear guidelines are available for …

Methods This study was reviewed by the University of Michigan Institutional Review Board
(IRB), considered IRB-exempt according to Exemption 4 (iii) at 45 CFR 46.104 (d) as …